CN Patent

CN110128355A — 一种含有6-甲基尿嘧啶结构化合物的制备方法

Assigned to CHENGDA PHARMACEUTICALS Co Ltd · Expires 2019-08-16 · 7y expired

What this patent protects

本申请涉及医药中间体6‑甲基尿嘧啶衍生物的制备方法和应用，以及其制备过程中所涉及的一种新化合物。与现有技术相比，此方法反应收率高，原子经济性好，反应过程操作简单，易于放大生产。

USPTO Abstract

本申请涉及医药中间体6‑甲基尿嘧啶衍生物的制备方法和应用，以及其制备过程中所涉及的一种新化合物。与现有技术相比，此方法反应收率高，原子经济性好，反应过程操作简单，易于放大生产。

Drugs covered by this patent

Patent Metadata

Patent number: CN110128355A
Jurisdiction: CN
Classification: —
Expires: 2019-08-16
Drug substance claim: No
Drug product claim: No
Assignee: CHENGDA PHARMACEUTICALS Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.